nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Levobunolol—Timolol—migraine	0.168	0.359	CrCrCtD
Salbutamol—Bupranolol—Timolol—migraine	0.122	0.259	CrCrCtD
Salbutamol—Levobunolol—Propranolol—migraine	0.0896	0.191	CrCrCtD
Salbutamol—Carteolol—Propranolol—migraine	0.0896	0.191	CrCrCtD
Salbutamol—ADRB2—Timolol—migraine	0.0862	0.231	CbGbCtD
Salbutamol—ADRB1—Timolol—migraine	0.0849	0.227	CbGbCtD
Salbutamol—ADRB2—Propranolol—migraine	0.0768	0.206	CbGbCtD
Salbutamol—ADRB1—Propranolol—migraine	0.0757	0.203	CbGbCtD
Salbutamol—CYP3A4—Propranolol—migraine	0.0123	0.0328	CbGbCtD
Salbutamol—CYP3A4—Amitriptyline—migraine	0.0106	0.0284	CbGbCtD
Salbutamol—CYP3A4—Valproic Acid—migraine	0.00966	0.0259	CbGbCtD
Salbutamol—CYP3A4—Topiramate—migraine	0.00871	0.0233	CbGbCtD
Salbutamol—CYP3A4—Verapamil—migraine	0.00841	0.0225	CbGbCtD
Salbutamol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.00156	0.0401	CbGpPWpGaD
Salbutamol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.00156	0.0401	CbGpPWpGaD
Salbutamol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.00113	0.0291	CbGpPWpGaD
Salbutamol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.00111	0.0285	CbGpPWpGaD
Salbutamol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.00105	0.0271	CbGpPWpGaD
Salbutamol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.00103	0.0265	CbGpPWpGaD
Salbutamol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.000952	0.0245	CbGpPWpGaD
Salbutamol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.000932	0.0239	CbGpPWpGaD
Salbutamol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.000885	0.0227	CbGpPWpGaD
Salbutamol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.000866	0.0222	CbGpPWpGaD
Salbutamol—Clenbuterol—TNF—migraine	0.00075	0.704	CrCbGaD
Salbutamol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000686	0.0176	CbGpPWpGaD
Salbutamol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.000672	0.0172	CbGpPWpGaD
Salbutamol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000661	0.017	CbGpPWpGaD
Salbutamol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000646	0.0166	CbGpPWpGaD
Salbutamol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000638	0.0164	CbGpPWpGaD
Salbutamol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000624	0.016	CbGpPWpGaD
Salbutamol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.000621	0.0159	CbGpPWpGaD
Salbutamol—ADRB1—Endothelin Pathways—CALCA—migraine	0.000598	0.0153	CbGpPWpGaD
Salbutamol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000577	0.0148	CbGpPWpGaD
Salbutamol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000564	0.0145	CbGpPWpGaD
Salbutamol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000559	0.0144	CbGpPWpGaD
Salbutamol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000555	0.0143	CbGpPWpGaD
Salbutamol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000547	0.014	CbGpPWpGaD
Salbutamol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000543	0.014	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000541	0.0139	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000541	0.0139	CbGpPWpGaD
Salbutamol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.000536	0.0138	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.000529	0.0136	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000529	0.0136	CbGpPWpGaD
Salbutamol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000525	0.0135	CbGpPWpGaD
Salbutamol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.00047	0.0121	CbGpPWpGaD
Salbutamol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.00046	0.0118	CbGpPWpGaD
Salbutamol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000391	0.0101	CbGpPWpGaD
Salbutamol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.000383	0.00984	CbGpPWpGaD
Salbutamol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000354	0.00909	CbGpPWpGaD
Salbutamol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000346	0.00889	CbGpPWpGaD
Salbutamol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000329	0.00845	CbGpPWpGaD
Salbutamol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.000322	0.00827	CbGpPWpGaD
Salbutamol—Epinephrine—TNF—migraine	0.000315	0.296	CrCbGaD
Salbutamol—ADRB2—GPCRs, Other—EDNRA—migraine	0.00027	0.00693	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Other—HTR7—migraine	0.000243	0.00624	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.000226	0.0058	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000221	0.00567	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000219	0.00562	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000214	0.00549	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—CALCA—migraine	0.000207	0.00532	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000203	0.00522	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—CALCA—migraine	0.000203	0.00521	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000199	0.00511	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—RAMP1—migraine	0.000196	0.00504	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CALCRL—migraine	0.000196	0.00504	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—HTR7—migraine	0.000194	0.00498	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—RAMP1—migraine	0.000192	0.00493	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CALCRL—migraine	0.000192	0.00493	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—HTR7—migraine	0.00019	0.00487	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000187	0.00481	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000183	0.00471	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000174	0.00447	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00017	0.00438	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Other—HTR2A—migraine	0.00017	0.00437	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR1D—migraine	0.000143	0.00366	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR1D—migraine	0.00014	0.00358	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR2B—migraine	0.000133	0.00341	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000132	0.0034	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR2B—migraine	0.00013	0.00333	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00013	0.00333	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000128	0.00328	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000125	0.0032	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000123	0.00316	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00012	0.00309	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00012	0.00308	CbGpPWpGaD
Salbutamol—Stomatitis—Topiramate—migraine	0.000118	0.001	CcSEcCtD
Salbutamol—Urinary tract infection—Topiramate—migraine	0.000118	0.000998	CcSEcCtD
Salbutamol—Conjunctivitis—Topiramate—migraine	0.000118	0.000998	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000117	0.00301	CbGpPWpGaD
Salbutamol—Nervousness—Timolol—migraine	0.000117	0.000994	CcSEcCtD
Salbutamol—Hypertension—Valproic Acid—migraine	0.000117	0.000993	CcSEcCtD
Salbutamol—Immune system disorder—Gabapentin—migraine	0.000117	0.000989	CcSEcCtD
Salbutamol—Mediastinal disorder—Gabapentin—migraine	0.000116	0.000987	CcSEcCtD
Salbutamol—Diarrhoea—Propranolol—migraine	0.000116	0.000985	CcSEcCtD
Salbutamol—Chills—Gabapentin—migraine	0.000116	0.000983	CcSEcCtD
Salbutamol—Chest pain—Valproic Acid—migraine	0.000115	0.000979	CcSEcCtD
Salbutamol—Myalgia—Valproic Acid—migraine	0.000115	0.000979	CcSEcCtD
Salbutamol—Arthralgia—Valproic Acid—migraine	0.000115	0.000979	CcSEcCtD
Salbutamol—Haematuria—Topiramate—migraine	0.000115	0.000979	CcSEcCtD
Salbutamol—Anxiety—Valproic Acid—migraine	0.000115	0.000976	CcSEcCtD
Salbutamol—Hypersensitivity—Verapamil—migraine	0.000115	0.000975	CcSEcCtD
Salbutamol—Epistaxis—Topiramate—migraine	0.000114	0.000968	CcSEcCtD
Salbutamol—Discomfort—Valproic Acid—migraine	0.000114	0.000967	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000113	0.00292	CbGpPWpGaD
Salbutamol—Sinusitis—Topiramate—migraine	0.000113	0.000963	CcSEcCtD
Salbutamol—Mental disorder—Gabapentin—migraine	0.000113	0.00096	CcSEcCtD
Salbutamol—Dry mouth—Valproic Acid—migraine	0.000113	0.000958	CcSEcCtD
Salbutamol—Malnutrition—Gabapentin—migraine	0.000112	0.000953	CcSEcCtD
Salbutamol—Dizziness—Propranolol—migraine	0.000112	0.000952	CcSEcCtD
Salbutamol—Asthenia—Verapamil—migraine	0.000112	0.00095	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000111	0.00285	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—RAMP1—migraine	0.000111	0.00285	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CALCRL—migraine	0.000111	0.00285	CbGpPWpGaD
Salbutamol—Flatulence—Gabapentin—migraine	0.000111	0.00094	CcSEcCtD
Salbutamol—Oedema—Valproic Acid—migraine	0.000111	0.000939	CcSEcCtD
Salbutamol—Anaphylactic shock—Valproic Acid—migraine	0.000111	0.000939	CcSEcCtD
Salbutamol—Pruritus—Verapamil—migraine	0.00011	0.000937	CcSEcCtD
Salbutamol—Tension—Gabapentin—migraine	0.00011	0.000936	CcSEcCtD
Salbutamol—Angioedema—Timolol—migraine	0.00011	0.000936	CcSEcCtD
Salbutamol—Dysgeusia—Gabapentin—migraine	0.00011	0.000934	CcSEcCtD
Salbutamol—Infection—Valproic Acid—migraine	0.00011	0.000933	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000109	0.00281	CbGpPWpGaD
Salbutamol—Haemoglobin—Topiramate—migraine	0.000109	0.000926	CcSEcCtD
Salbutamol—Nervousness—Gabapentin—migraine	0.000109	0.000926	CcSEcCtD
Salbutamol—Rhinitis—Topiramate—migraine	0.000109	0.000924	CcSEcCtD
Salbutamol—Back pain—Gabapentin—migraine	0.000109	0.000922	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—CALCRL—migraine	0.000109	0.00279	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—RAMP1—migraine	0.000109	0.00279	CbGpPWpGaD
Salbutamol—Haemorrhage—Topiramate—migraine	0.000109	0.000921	CcSEcCtD
Salbutamol—Nervous system disorder—Valproic Acid—migraine	0.000108	0.000921	CcSEcCtD
Salbutamol—Vertigo—Timolol—migraine	0.000108	0.00092	CcSEcCtD
Salbutamol—Syncope—Timolol—migraine	0.000108	0.000918	CcSEcCtD
Salbutamol—Hypoaesthesia—Topiramate—migraine	0.000108	0.000917	CcSEcCtD
Salbutamol—Muscle spasms—Gabapentin—migraine	0.000108	0.000917	CcSEcCtD
Salbutamol—Tachycardia—Valproic Acid—migraine	0.000108	0.000916	CcSEcCtD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000108	0.00277	CbGpPWpGaD
Salbutamol—Vomiting—Propranolol—migraine	0.000108	0.000915	CcSEcCtD
Salbutamol—Pharyngitis—Topiramate—migraine	0.000108	0.000915	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000108	0.00276	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000108	0.00276	CbGpPWpGaD
Salbutamol—Skin disorder—Valproic Acid—migraine	0.000107	0.000912	CcSEcCtD
Salbutamol—Urinary tract disorder—Topiramate—migraine	0.000107	0.00091	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000107	0.00274	CbGpPWpGaD
Salbutamol—Hyperhidrosis—Valproic Acid—migraine	0.000107	0.000907	CcSEcCtD
Salbutamol—Rash—Propranolol—migraine	0.000107	0.000907	CcSEcCtD
Salbutamol—Dermatitis—Propranolol—migraine	0.000107	0.000907	CcSEcCtD
Salbutamol—Diarrhoea—Verapamil—migraine	0.000107	0.000906	CcSEcCtD
Salbutamol—Connective tissue disorder—Topiramate—migraine	0.000107	0.000905	CcSEcCtD
Salbutamol—Palpitations—Timolol—migraine	0.000107	0.000905	CcSEcCtD
Salbutamol—Urethral disorder—Topiramate—migraine	0.000106	0.000903	CcSEcCtD
Salbutamol—Loss of consciousness—Timolol—migraine	0.000106	0.0009	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000106	0.00271	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000106	0.00271	CbGpPWpGaD
Salbutamol—Anorexia—Valproic Acid—migraine	0.000105	0.000895	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000105	0.0027	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000105	0.0027	CbGpPWpGaD
Salbutamol—Cough—Timolol—migraine	0.000105	0.000893	CcSEcCtD
Salbutamol—Tremor—Gabapentin—migraine	0.000105	0.000893	CcSEcCtD
Salbutamol—Ill-defined disorder—Gabapentin—migraine	0.000104	0.000885	CcSEcCtD
Salbutamol—Hypertension—Timolol—migraine	0.000104	0.000884	CcSEcCtD
Salbutamol—Hypotension—Valproic Acid—migraine	0.000103	0.000877	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000103	0.00265	CbGpPWpGaD
Salbutamol—Agitation—Gabapentin—migraine	0.000103	0.000876	CcSEcCtD
Salbutamol—Dizziness—Verapamil—migraine	0.000103	0.000875	CcSEcCtD
Salbutamol—Chest pain—Timolol—migraine	0.000103	0.000872	CcSEcCtD
Salbutamol—Myalgia—Timolol—migraine	0.000103	0.000872	CcSEcCtD
Salbutamol—Arthralgia—Timolol—migraine	0.000103	0.000872	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000103	0.00264	CbGpPWpGaD
Salbutamol—Angioedema—Gabapentin—migraine	0.000103	0.000871	CcSEcCtD
Salbutamol—Anxiety—Timolol—migraine	0.000102	0.000869	CcSEcCtD
Salbutamol—Discomfort—Timolol—migraine	0.000101	0.000861	CcSEcCtD
Salbutamol—Malaise—Gabapentin—migraine	0.000101	0.00086	CcSEcCtD
Salbutamol—Tinnitus—Topiramate—migraine	0.000101	0.000859	CcSEcCtD
Salbutamol—Vertigo—Gabapentin—migraine	0.000101	0.000857	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—RAMP1—migraine	0.000101	0.00259	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CALCRL—migraine	0.000101	0.00259	CbGpPWpGaD
Salbutamol—Musculoskeletal discomfort—Valproic Acid—migraine	0.000101	0.000855	CcSEcCtD
Salbutamol—Flushing—Topiramate—migraine	0.000101	0.000855	CcSEcCtD
Salbutamol—Cardiac disorder—Topiramate—migraine	0.000101	0.000855	CcSEcCtD
Salbutamol—Syncope—Gabapentin—migraine	0.000101	0.000855	CcSEcCtD
Salbutamol—Nausea—Propranolol—migraine	0.000101	0.000855	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.0001	0.00258	CbGpPWpGaD
Salbutamol—Dry mouth—Timolol—migraine	0.0001	0.000852	CcSEcCtD
Salbutamol—Insomnia—Valproic Acid—migraine	0.0001	0.000849	CcSEcCtD
Salbutamol—Paraesthesia—Valproic Acid—migraine	9.93e-05	0.000843	CcSEcCtD
Salbutamol—Palpitations—Gabapentin—migraine	9.92e-05	0.000843	CcSEcCtD
Salbutamol—Vomiting—Verapamil—migraine	9.91e-05	0.000842	CcSEcCtD
Salbutamol—Loss of consciousness—Gabapentin—migraine	9.87e-05	0.000838	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—CALCRL—migraine	9.86e-05	0.00253	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—RAMP1—migraine	9.86e-05	0.00253	CbGpPWpGaD
Salbutamol—Dyspnoea—Valproic Acid—migraine	9.86e-05	0.000837	CcSEcCtD
Salbutamol—Angiopathy—Topiramate—migraine	9.85e-05	0.000836	CcSEcCtD
Salbutamol—Oedema—Timolol—migraine	9.84e-05	0.000836	CcSEcCtD
Salbutamol—Anaphylactic shock—Timolol—migraine	9.84e-05	0.000836	CcSEcCtD
Salbutamol—Rash—Verapamil—migraine	9.83e-05	0.000835	CcSEcCtD
Salbutamol—Somnolence—Valproic Acid—migraine	9.83e-05	0.000834	CcSEcCtD
Salbutamol—Dermatitis—Verapamil—migraine	9.82e-05	0.000834	CcSEcCtD
Salbutamol—Immune system disorder—Topiramate—migraine	9.8e-05	0.000832	CcSEcCtD
Salbutamol—Cough—Gabapentin—migraine	9.8e-05	0.000832	CcSEcCtD
Salbutamol—Mediastinal disorder—Topiramate—migraine	9.78e-05	0.00083	CcSEcCtD
Salbutamol—Infection—Timolol—migraine	9.78e-05	0.00083	CcSEcCtD
Salbutamol—Headache—Verapamil—migraine	9.77e-05	0.000829	CcSEcCtD
Salbutamol—Chills—Topiramate—migraine	9.74e-05	0.000827	CcSEcCtD
Salbutamol—Dyspepsia—Valproic Acid—migraine	9.73e-05	0.000826	CcSEcCtD
Salbutamol—Hypertension—Gabapentin—migraine	9.69e-05	0.000823	CcSEcCtD
Salbutamol—Shock—Timolol—migraine	9.68e-05	0.000822	CcSEcCtD
Salbutamol—Nervous system disorder—Timolol—migraine	9.65e-05	0.000819	CcSEcCtD
Salbutamol—Decreased appetite—Valproic Acid—migraine	9.61e-05	0.000816	CcSEcCtD
Salbutamol—Arthralgia—Gabapentin—migraine	9.56e-05	0.000812	CcSEcCtD
Salbutamol—Myalgia—Gabapentin—migraine	9.56e-05	0.000812	CcSEcCtD
Salbutamol—Chest pain—Gabapentin—migraine	9.56e-05	0.000812	CcSEcCtD
Salbutamol—Skin disorder—Timolol—migraine	9.56e-05	0.000812	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Valproic Acid—migraine	9.54e-05	0.00081	CcSEcCtD
Salbutamol—Fatigue—Valproic Acid—migraine	9.53e-05	0.000809	CcSEcCtD
Salbutamol—Anxiety—Gabapentin—migraine	9.53e-05	0.000809	CcSEcCtD
Salbutamol—Hyperhidrosis—Timolol—migraine	9.51e-05	0.000808	CcSEcCtD
Salbutamol—Mental disorder—Topiramate—migraine	9.51e-05	0.000807	CcSEcCtD
Salbutamol—Pain—Valproic Acid—migraine	9.45e-05	0.000803	CcSEcCtD
Salbutamol—Constipation—Valproic Acid—migraine	9.45e-05	0.000803	CcSEcCtD
Salbutamol—Malnutrition—Topiramate—migraine	9.45e-05	0.000802	CcSEcCtD
Salbutamol—Discomfort—Gabapentin—migraine	9.44e-05	0.000802	CcSEcCtD
Salbutamol—Anorexia—Timolol—migraine	9.38e-05	0.000797	CcSEcCtD
Salbutamol—Dry mouth—Gabapentin—migraine	9.35e-05	0.000794	CcSEcCtD
Salbutamol—Flatulence—Topiramate—migraine	9.31e-05	0.00079	CcSEcCtD
Salbutamol—Tension—Topiramate—migraine	9.27e-05	0.000787	CcSEcCtD
Salbutamol—Nausea—Verapamil—migraine	9.26e-05	0.000786	CcSEcCtD
Salbutamol—Dysgeusia—Topiramate—migraine	9.25e-05	0.000786	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	9.24e-05	0.00237	CbGpPWpGaD
Salbutamol—Hypotension—Timolol—migraine	9.2e-05	0.000781	CcSEcCtD
Salbutamol—Nervousness—Topiramate—migraine	9.17e-05	0.000779	CcSEcCtD
Salbutamol—Oedema—Gabapentin—migraine	9.16e-05	0.000778	CcSEcCtD
Salbutamol—Anaphylactic shock—Gabapentin—migraine	9.16e-05	0.000778	CcSEcCtD
Salbutamol—Back pain—Topiramate—migraine	9.14e-05	0.000776	CcSEcCtD
Salbutamol—Feeling abnormal—Valproic Acid—migraine	9.11e-05	0.000774	CcSEcCtD
Salbutamol—Infection—Gabapentin—migraine	9.1e-05	0.000773	CcSEcCtD
Salbutamol—Muscle spasms—Topiramate—migraine	9.08e-05	0.000771	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	9.04e-05	0.00232	CbGpPWpGaD
Salbutamol—Gastrointestinal pain—Valproic Acid—migraine	9.04e-05	0.000768	CcSEcCtD
Salbutamol—Shock—Gabapentin—migraine	9.02e-05	0.000766	CcSEcCtD
Salbutamol—Nervous system disorder—Gabapentin—migraine	8.99e-05	0.000763	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Timolol—migraine	8.97e-05	0.000761	CcSEcCtD
Salbutamol—Tachycardia—Gabapentin—migraine	8.94e-05	0.000759	CcSEcCtD
Salbutamol—Skin disorder—Gabapentin—migraine	8.9e-05	0.000756	CcSEcCtD
Salbutamol—Insomnia—Timolol—migraine	8.9e-05	0.000756	CcSEcCtD
Salbutamol—Hyperhidrosis—Gabapentin—migraine	8.86e-05	0.000752	CcSEcCtD
Salbutamol—Tremor—Topiramate—migraine	8.85e-05	0.000752	CcSEcCtD
Salbutamol—Paraesthesia—Timolol—migraine	8.84e-05	0.00075	CcSEcCtD
Salbutamol—Urticaria—Valproic Acid—migraine	8.78e-05	0.000746	CcSEcCtD
Salbutamol—Dyspnoea—Timolol—migraine	8.77e-05	0.000745	CcSEcCtD
Salbutamol—Ill-defined disorder—Topiramate—migraine	8.76e-05	0.000744	CcSEcCtD
Salbutamol—Somnolence—Timolol—migraine	8.75e-05	0.000743	CcSEcCtD
Salbutamol—Body temperature increased—Valproic Acid—migraine	8.74e-05	0.000742	CcSEcCtD
Salbutamol—Abdominal pain—Valproic Acid—migraine	8.74e-05	0.000742	CcSEcCtD
Salbutamol—Anorexia—Gabapentin—migraine	8.74e-05	0.000742	CcSEcCtD
Salbutamol—Agitation—Topiramate—migraine	8.68e-05	0.000737	CcSEcCtD
Salbutamol—Dyspepsia—Timolol—migraine	8.66e-05	0.000736	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—HTR1B—migraine	8.64e-05	0.00222	CbGpPWpGaD
Salbutamol—Hypotension—Gabapentin—migraine	8.56e-05	0.000727	CcSEcCtD
Salbutamol—Decreased appetite—Timolol—migraine	8.55e-05	0.000726	CcSEcCtD
Salbutamol—Malaise—Topiramate—migraine	8.52e-05	0.000723	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Timolol—migraine	8.5e-05	0.000721	CcSEcCtD
Salbutamol—Vertigo—Topiramate—migraine	8.49e-05	0.000721	CcSEcCtD
Salbutamol—Fatigue—Timolol—migraine	8.48e-05	0.00072	CcSEcCtD
Salbutamol—Syncope—Topiramate—migraine	8.47e-05	0.000719	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—HTR1B—migraine	8.45e-05	0.00217	CbGpPWpGaD
Salbutamol—Pain—Timolol—migraine	8.42e-05	0.000715	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Gabapentin—migraine	8.35e-05	0.000709	CcSEcCtD
Salbutamol—Palpitations—Topiramate—migraine	8.35e-05	0.000709	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—HTR1A—migraine	8.32e-05	0.00214	CbGpPWpGaD
Salbutamol—Loss of consciousness—Topiramate—migraine	8.3e-05	0.000705	CcSEcCtD
Salbutamol—Insomnia—Gabapentin—migraine	8.29e-05	0.000704	CcSEcCtD
Salbutamol—Cough—Topiramate—migraine	8.24e-05	0.0007	CcSEcCtD
Salbutamol—Paraesthesia—Gabapentin—migraine	8.23e-05	0.000699	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—NPS—migraine	8.19e-05	0.0021	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—TAC1—migraine	8.19e-05	0.0021	CbGpPWpGaD
Salbutamol—Dyspnoea—Gabapentin—migraine	8.17e-05	0.000694	CcSEcCtD
Salbutamol—Hypertension—Topiramate—migraine	8.16e-05	0.000693	CcSEcCtD
Salbutamol—Somnolence—Gabapentin—migraine	8.15e-05	0.000692	CcSEcCtD
Salbutamol—Hypersensitivity—Valproic Acid—migraine	8.14e-05	0.000692	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—HTR1A—migraine	8.14e-05	0.00209	CbGpPWpGaD
Salbutamol—Feeling abnormal—Timolol—migraine	8.11e-05	0.000689	CcSEcCtD
Salbutamol—Dyspepsia—Gabapentin—migraine	8.07e-05	0.000685	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—HTR1D—migraine	8.06e-05	0.00207	CbGpPWpGaD
Salbutamol—Gastrointestinal pain—Timolol—migraine	8.05e-05	0.000683	CcSEcCtD
Salbutamol—Myalgia—Topiramate—migraine	8.04e-05	0.000683	CcSEcCtD
Salbutamol—Chest pain—Topiramate—migraine	8.04e-05	0.000683	CcSEcCtD
Salbutamol—Arthralgia—Topiramate—migraine	8.04e-05	0.000683	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—HTR2C—migraine	8.04e-05	0.00206	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—TAC1—migraine	8.02e-05	0.00206	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—NPS—migraine	8.02e-05	0.00206	CbGpPWpGaD
Salbutamol—Anxiety—Topiramate—migraine	8.01e-05	0.000681	CcSEcCtD
Salbutamol—Decreased appetite—Gabapentin—migraine	7.97e-05	0.000676	CcSEcCtD
Salbutamol—Discomfort—Topiramate—migraine	7.95e-05	0.000675	CcSEcCtD
Salbutamol—Asthenia—Valproic Acid—migraine	7.93e-05	0.000673	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Gabapentin—migraine	7.91e-05	0.000672	CcSEcCtD
Salbutamol—Fatigue—Gabapentin—migraine	7.9e-05	0.000671	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—HTR1D—migraine	7.89e-05	0.00203	CbGpPWpGaD
Salbutamol—Dry mouth—Topiramate—migraine	7.87e-05	0.000668	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—HTR2C—migraine	7.86e-05	0.00202	CbGpPWpGaD
Salbutamol—Pain—Gabapentin—migraine	7.84e-05	0.000665	CcSEcCtD
Salbutamol—Constipation—Gabapentin—migraine	7.84e-05	0.000665	CcSEcCtD
Salbutamol—Pruritus—Valproic Acid—migraine	7.82e-05	0.000664	CcSEcCtD
Salbutamol—Urticaria—Timolol—migraine	7.82e-05	0.000664	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—EDNRA—migraine	7.82e-05	0.00201	CbGpPWpGaD
Salbutamol—Body temperature increased—Timolol—migraine	7.78e-05	0.000661	CcSEcCtD
Salbutamol—Abdominal pain—Timolol—migraine	7.78e-05	0.000661	CcSEcCtD
Salbutamol—Oedema—Topiramate—migraine	7.71e-05	0.000655	CcSEcCtD
Salbutamol—Infection—Topiramate—migraine	7.66e-05	0.00065	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—EDNRA—migraine	7.65e-05	0.00196	CbGpPWpGaD
Salbutamol—Shock—Topiramate—migraine	7.59e-05	0.000644	CcSEcCtD
Salbutamol—Diarrhoea—Valproic Acid—migraine	7.56e-05	0.000642	CcSEcCtD
Salbutamol—Nervous system disorder—Topiramate—migraine	7.56e-05	0.000642	CcSEcCtD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	7.56e-05	0.00194	CbGpPWpGaD
Salbutamol—Feeling abnormal—Gabapentin—migraine	7.55e-05	0.000641	CcSEcCtD
Salbutamol—Tachycardia—Topiramate—migraine	7.52e-05	0.000639	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—CALCA—migraine	7.52e-05	0.00193	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2B—migraine	7.49e-05	0.00192	CbGpPWpGaD
Salbutamol—Gastrointestinal pain—Gabapentin—migraine	7.49e-05	0.000636	CcSEcCtD
Salbutamol—Skin disorder—Topiramate—migraine	7.49e-05	0.000636	CcSEcCtD
Salbutamol—Hyperhidrosis—Topiramate—migraine	7.45e-05	0.000633	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	7.39e-05	0.0019	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CALCA—migraine	7.36e-05	0.00189	CbGpPWpGaD
Salbutamol—Anorexia—Topiramate—migraine	7.35e-05	0.000624	CcSEcCtD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2B—migraine	7.33e-05	0.00188	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR1D—migraine	7.32e-05	0.00188	CbGpPWpGaD
Salbutamol—Dizziness—Valproic Acid—migraine	7.31e-05	0.000621	CcSEcCtD
Salbutamol—Urticaria—Gabapentin—migraine	7.28e-05	0.000618	CcSEcCtD
Salbutamol—Hypersensitivity—Timolol—migraine	7.25e-05	0.000616	CcSEcCtD
Salbutamol—Abdominal pain—Gabapentin—migraine	7.24e-05	0.000615	CcSEcCtD
Salbutamol—Body temperature increased—Gabapentin—migraine	7.24e-05	0.000615	CcSEcCtD
Salbutamol—Hypotension—Topiramate—migraine	7.2e-05	0.000612	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—HTR1D—migraine	7.16e-05	0.00184	CbGpPWpGaD
Salbutamol—Asthenia—Timolol—migraine	7.06e-05	0.0006	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—HTR7—migraine	7.04e-05	0.00181	CbGpPWpGaD
Salbutamol—Vomiting—Valproic Acid—migraine	7.03e-05	0.000597	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Topiramate—migraine	7.02e-05	0.000596	CcSEcCtD
Salbutamol—Insomnia—Topiramate—migraine	6.97e-05	0.000592	CcSEcCtD
Salbutamol—Rash—Valproic Acid—migraine	6.97e-05	0.000592	CcSEcCtD
Salbutamol—Dermatitis—Valproic Acid—migraine	6.96e-05	0.000591	CcSEcCtD
Salbutamol—Pruritus—Timolol—migraine	6.96e-05	0.000591	CcSEcCtD
Salbutamol—Headache—Valproic Acid—migraine	6.93e-05	0.000588	CcSEcCtD
Salbutamol—Paraesthesia—Topiramate—migraine	6.92e-05	0.000588	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—HTR7—migraine	6.88e-05	0.00177	CbGpPWpGaD
Salbutamol—Dyspnoea—Topiramate—migraine	6.87e-05	0.000584	CcSEcCtD
Salbutamol—Somnolence—Topiramate—migraine	6.85e-05	0.000582	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—HTR2B—migraine	6.81e-05	0.00175	CbGpPWpGaD
Salbutamol—Dyspepsia—Topiramate—migraine	6.79e-05	0.000576	CcSEcCtD
Salbutamol—Hypersensitivity—Gabapentin—migraine	6.75e-05	0.000573	CcSEcCtD
Salbutamol—Diarrhoea—Timolol—migraine	6.73e-05	0.000572	CcSEcCtD
Salbutamol—Decreased appetite—Topiramate—migraine	6.7e-05	0.000569	CcSEcCtD
Salbutamol—ADRB2—Signaling by GPCR—HTR2B—migraine	6.66e-05	0.00171	CbGpPWpGaD
Salbutamol—Gastrointestinal disorder—Topiramate—migraine	6.66e-05	0.000565	CcSEcCtD
Salbutamol—Fatigue—Topiramate—migraine	6.65e-05	0.000564	CcSEcCtD
Salbutamol—Constipation—Topiramate—migraine	6.59e-05	0.00056	CcSEcCtD
Salbutamol—Pain—Topiramate—migraine	6.59e-05	0.00056	CcSEcCtD
Salbutamol—Asthenia—Gabapentin—migraine	6.57e-05	0.000558	CcSEcCtD
Salbutamol—Nausea—Valproic Acid—migraine	6.57e-05	0.000558	CcSEcCtD
Salbutamol—Dizziness—Timolol—migraine	6.51e-05	0.000553	CcSEcCtD
Salbutamol—Pruritus—Gabapentin—migraine	6.48e-05	0.000551	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	6.47e-05	0.00166	CbGpPWpGaD
Salbutamol—Feeling abnormal—Topiramate—migraine	6.35e-05	0.000539	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	6.33e-05	0.00163	CbGpPWpGaD
Salbutamol—Gastrointestinal pain—Topiramate—migraine	6.3e-05	0.000535	CcSEcCtD
Salbutamol—Diarrhoea—Gabapentin—migraine	6.27e-05	0.000532	CcSEcCtD
Salbutamol—Vomiting—Timolol—migraine	6.26e-05	0.000531	CcSEcCtD
Salbutamol—Rash—Timolol—migraine	6.2e-05	0.000527	CcSEcCtD
Salbutamol—Dermatitis—Timolol—migraine	6.2e-05	0.000526	CcSEcCtD
Salbutamol—Headache—Timolol—migraine	6.16e-05	0.000523	CcSEcCtD
Salbutamol—Urticaria—Topiramate—migraine	6.12e-05	0.00052	CcSEcCtD
Salbutamol—Abdominal pain—Topiramate—migraine	6.09e-05	0.000518	CcSEcCtD
Salbutamol—Body temperature increased—Topiramate—migraine	6.09e-05	0.000518	CcSEcCtD
Salbutamol—Dizziness—Gabapentin—migraine	6.06e-05	0.000515	CcSEcCtD
Salbutamol—ADRB1—Signaling Pathways—CALCRL—migraine	5.95e-05	0.00153	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RAMP1—migraine	5.95e-05	0.00153	CbGpPWpGaD
Salbutamol—Nausea—Timolol—migraine	5.85e-05	0.000496	CcSEcCtD
Salbutamol—Vomiting—Gabapentin—migraine	5.83e-05	0.000495	CcSEcCtD
Salbutamol—ADRB2—Signaling Pathways—RAMP1—migraine	5.82e-05	0.0015	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CALCRL—migraine	5.82e-05	0.0015	CbGpPWpGaD
Salbutamol—Rash—Gabapentin—migraine	5.78e-05	0.000491	CcSEcCtD
Salbutamol—Dermatitis—Gabapentin—migraine	5.77e-05	0.00049	CcSEcCtD
Salbutamol—Headache—Gabapentin—migraine	5.74e-05	0.000487	CcSEcCtD
Salbutamol—Hypersensitivity—Topiramate—migraine	5.68e-05	0.000482	CcSEcCtD
Salbutamol—Asthenia—Topiramate—migraine	5.53e-05	0.00047	CcSEcCtD
Salbutamol—Pruritus—Topiramate—migraine	5.45e-05	0.000463	CcSEcCtD
Salbutamol—Nausea—Gabapentin—migraine	5.44e-05	0.000462	CcSEcCtD
Salbutamol—Diarrhoea—Topiramate—migraine	5.28e-05	0.000448	CcSEcCtD
Salbutamol—Dizziness—Topiramate—migraine	5.1e-05	0.000433	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—HTR2A—migraine	4.93e-05	0.00127	CbGpPWpGaD
Salbutamol—Vomiting—Topiramate—migraine	4.9e-05	0.000416	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—HTR1B—migraine	4.88e-05	0.00125	CbGpPWpGaD
Salbutamol—Rash—Topiramate—migraine	4.86e-05	0.000413	CcSEcCtD
Salbutamol—Dermatitis—Topiramate—migraine	4.86e-05	0.000412	CcSEcCtD
Salbutamol—Headache—Topiramate—migraine	4.83e-05	0.00041	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—HTR2A—migraine	4.82e-05	0.00124	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR1B—migraine	4.78e-05	0.00123	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR1A—migraine	4.7e-05	0.00121	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—TAC1—migraine	4.63e-05	0.00119	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—NPS—migraine	4.63e-05	0.00119	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR1A—migraine	4.6e-05	0.00118	CbGpPWpGaD
Salbutamol—Nausea—Topiramate—migraine	4.58e-05	0.000389	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2C—migraine	4.54e-05	0.00117	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—TAC1—migraine	4.53e-05	0.00116	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—NPS—migraine	4.53e-05	0.00116	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2C—migraine	4.44e-05	0.00114	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR1B—migraine	4.44e-05	0.00114	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—EDNRA—migraine	4.42e-05	0.00113	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR1B—migraine	4.34e-05	0.00111	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR1D—migraine	4.32e-05	0.00111	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—EDNRA—migraine	4.32e-05	0.00111	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR1A—migraine	4.27e-05	0.0011	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CALCA—migraine	4.25e-05	0.00109	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR1D—migraine	4.23e-05	0.00109	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—TAC1—migraine	4.2e-05	0.00108	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—NPS—migraine	4.2e-05	0.00108	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR1A—migraine	4.18e-05	0.00107	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CALCA—migraine	4.16e-05	0.00107	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2C—migraine	4.12e-05	0.00106	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—TAC1—migraine	4.11e-05	0.00106	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NPS—migraine	4.11e-05	0.00106	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2C—migraine	4.03e-05	0.00104	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2B—migraine	4.02e-05	0.00103	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—EDNRA—migraine	4.01e-05	0.00103	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR7—migraine	3.98e-05	0.00102	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2B—migraine	3.93e-05	0.00101	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—EDNRA—migraine	3.92e-05	0.00101	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR7—migraine	3.89e-05	0.000999	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CALCA—migraine	3.86e-05	0.000992	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CALCA—migraine	3.78e-05	0.00097	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR7—migraine	3.61e-05	0.000928	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LRP1—migraine	3.54e-05	0.000909	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR7—migraine	3.53e-05	0.000907	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LRP1—migraine	3.46e-05	0.000889	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2A—migraine	2.79e-05	0.000715	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2A—migraine	2.72e-05	0.0007	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOTCH4—migraine	2.72e-05	0.000698	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOTCH4—migraine	2.66e-05	0.000682	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR1B—migraine	2.62e-05	0.000673	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR1B—migraine	2.56e-05	0.000658	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2A—migraine	2.53e-05	0.00065	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR1A—migraine	2.52e-05	0.000648	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TAC1—migraine	2.48e-05	0.000638	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NPS—migraine	2.48e-05	0.000638	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PGR—migraine	2.48e-05	0.000638	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2A—migraine	2.47e-05	0.000636	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR1A—migraine	2.47e-05	0.000634	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2C—migraine	2.44e-05	0.000626	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPS—migraine	2.43e-05	0.000624	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PGR—migraine	2.43e-05	0.000624	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TAC1—migraine	2.43e-05	0.000624	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2C—migraine	2.38e-05	0.000612	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EDNRA—migraine	2.37e-05	0.000609	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EDNRA—migraine	2.32e-05	0.000595	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOTCH3—migraine	2.31e-05	0.000593	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CALCA—migraine	2.28e-05	0.000586	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOTCH3—migraine	2.26e-05	0.00058	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CALCA—migraine	2.23e-05	0.000573	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR7—migraine	2.13e-05	0.000548	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR7—migraine	2.09e-05	0.000536	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFBR2—migraine	1.84e-05	0.000472	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFBR2—migraine	1.8e-05	0.000462	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CACNA1A—migraine	1.73e-05	0.000444	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—migraine	1.49e-05	0.000384	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—migraine	1.46e-05	0.000375	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ESR1—migraine	1.33e-05	0.000341	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ESR1—migraine	1.3e-05	0.000333	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—migraine	5.72e-06	0.000147	CbGpPWpGaD
